Kronos Longevity Research Institute
Analysis indicates younger women may receive heart protection from estrogen therapy
Published in Cardiovascular Device Liability Week, March 12th, 2006
It also demonstrates that older women do not have heart benefits from estrogen therapy.
"This study further emphasizes the need for additional research on a younger group of women who are recently menopausal," said S. Mitchell Harman, director and president of Phoenix-based Kronos Longevity Research Institute (KLRI), a nonprofit that is spearheading the Kronos Early Estrogen Prevention Study...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Medical College of Wisconsin
Angiotensin II AT(1) receptor blockade spurs microvessel growth in the cerebral cortex - Medistem Laboratories, Inc.
Stem cell company licenses intellectual property to Institute for Cellular Medicine - Royal Melbourne Hospital
Alternatives to group cardiac rehabilitation would meet the needs of more patients - Trinity Center Health Science, Dublin
Adiponectin is predictor of aortic pulse wave velocity but not augmentation index - A.I. duPont Hospital for Children, Wilmington
Transthoracic percutaneous access aids mapping and ablation of atrial fibrillation - Aachen Technical University
New approaches with coronary magnetic resonance imaging are focus of review - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
